As of 3:58pm ET
| +0.39 / +5.74%|
The 6 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 8.50, with a high estimate of 11.00 and a low estimate of 7.00. The median estimate represents a +18.38% increase from the last price of 7.18.
The current consensus among 6 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.